SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (3380)10/9/2002 4:39:48 AM
From: nigel bates  Read Replies (1) | Respond to of 10345
 
c.Passive immunization with monoclonal antibodies against AB42 or its fragments (from Who?)

Would that be CATG ?
Message 15242343
Elan Corporation, plc and Cambridge Antibody Technology Create Major Alliance For Human Monoclonal Antibodies in Neurological Disease



To: Cacaito who wrote (3380)10/9/2002 5:35:43 PM
From: scaram(o)uche  Respond to of 10345
 
Thanks, very much, for your review.

My grandmother died of Alzheimer's. If she had been able to review "before" and "five year after" photos at an early stage of her disease, I'm certain that she would have opted to go for meningoencephalitis if there was any potential for a positive outcome.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News